Early Stage Clinical

QPS Respiratory News – QPS Research Affiliate Lectures on Allergen Challenge Testing at European Respiratory Society Annual Congress

Dr. Zuzana Diamant was a featured speaker at the ERS Annual Congress in Vienna, 1-5 September 2012. During the session on “New ATS/ERS Recommendations for Bronchoprovocation Challenge Testing,” she delivered a lecture on “Allergen Challenge in Clinical Asthma Research.” The allergen challenge is one of the clinical respiratory disease models now being implemented in our new Respiratory Research Unit at QPS Netherlands. 


Professor Diamant is broadly experienced with disease models and biomarkers in asthma, allergy and COPD. At QPS, she works with Dr.Tjeert Mensinga and our dedicated respiratory team to further develop and refine research methods and biomarkers for targeted therapeutic options in respiratory disease.

Current and Ongoing Respiratory Studies at QPS Netherlands

Presently, a Phase II study evaluating allergen-specific immunotherapy in the presence of a nasal allergen challenge is in progress. In Q3-2012, we expect to start an inhaled LPS biomarker study in healthy volunteers.

Schedule a meeting with us

Should you be interested in our respiratory capabilities, please contact Dr. Zuzana Diamant at zuzana.diamant@qps.com for tailored updates on our respiratory unit.

Missed us at the ERS? Meet us at Partnerships in Clinical Trials, 6 - 9 November 2012, CCH Congress Center, Hamburg, Germany. Please contact Edwin van Vulpen at edwin.van.vulpen@qps.com

20 years in pharma R&D navigation